Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.

Nicolodi C, Groiss F, Kiselev O, Wolschek M, Seipelt J, Muster T.

Vaccine. 2019 Jun 19;37(28):3722-3729. doi: 10.1016/j.vaccine.2019.05.013. Epub 2019 May 30.

PMID:
31155415
2.

Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour.

Schmid F, Brodesser D, Reifinger M, Forte S, Semp P, Eberspächer-Schweda MC, Wolschek M, Brandt S, Kleiter M, Pratscher B.

Vet Comp Oncol. 2019 Sep;17(3):211-220. doi: 10.1111/vco.12464. Epub 2019 May 29.

PMID:
30719836
3.

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Jindra C, Huber B, Shafti-Keramat S, Wolschek M, Ferko B, Muster T, Brandt S, Kirnbauer R.

PLoS One. 2015 Nov 12;10(11):e0143269. doi: 10.1371/journal.pone.0143269. eCollection 2015. No abstract available.

4.

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Jindra C, Huber B, Shafti-Keramat S, Wolschek M, Ferko B, Muster T, Brandt S, Kirnbauer R.

PLoS One. 2015 Sep 18;10(9):e0138722. doi: 10.1371/journal.pone.0138722. eCollection 2015. Erratum in: PLoS One. 2015;10(11):e0143269.

5.

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.

Kittel C, Wressnigg N, Shurygina AP, Wolschek M, Stukova M, Romanovskaya-Romanko E, Romanova J, Kiselev O, Muster T, Egorov A.

Arch Virol. 2015 Oct;160(10):2525-34. doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.

PMID:
26215439
6.

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

Kuznetsova I, Shurygina AP, Wolf B, Wolschek M, Enzmann F, Sansyzbay A, Khairullin B, Sandybayev N, Stukova M, Kiselev O, Egorov A, Bergmann M.

J Gen Virol. 2014 Feb;95(Pt 2):337-49. doi: 10.1099/vir.0.056036-0. Epub 2013 Nov 12.

PMID:
24222196
7.

Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1.

Mössler C, Groiss F, Wolzt M, Wolschek M, Seipelt J, Muster T.

Vaccine. 2013 Dec 16;31(52):6194-200. doi: 10.1016/j.vaccine.2013.10.061. Epub 2013 Oct 30.

PMID:
24183981
8.

Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.

van Rikxoort M, Michaelis M, Wolschek M, Muster T, Egorov A, Seipelt J, Doerr HW, Cinatl J Jr.

PLoS One. 2012;7(5):e36506. doi: 10.1371/journal.pone.0036506. Epub 2012 May 1.

9.

Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.

Roethl E, Gassner M, Krenn BM, Romanovskaya-Romanko EA, Seper H, Romanova J, Nakowitsch S, Sturlan S, Wolschek M, Sirotkin A, Kiselev O, Muster T, Egorov A.

J Virol. 2011 Nov;85(21):11139-45. doi: 10.1128/JVI.00169-11. Epub 2011 Aug 17.

10.

Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1.

Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, Cinatl J, Michaelis M, Wressnigg N, Sturlan S, Ferko B, Batishchev OV, Indenbom AV, Zhu R, Kastner M, Hinterdorfer P, Kiselev O, Muster T, Romanova J.

PLoS One. 2011 Apr 7;6(4):e18577. doi: 10.1371/journal.pone.0018577.

11.

Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.

Nakowitsch S, Wolschek M, Morokutti A, Ruthsatz T, Krenn BM, Ferko B, Ferstl N, Triendl A, Muster T, Egorov A, Romanova J.

Vaccine. 2011 Apr 27;29(19):3517-24. doi: 10.1016/j.vaccine.2011.02.100. Epub 2011 Mar 12.

PMID:
21406268
12.

Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Wolschek M, Samm E, Seper H, Sturlan S, Kuznetsova I, Schwager C, Khassidov A, Kittel C, Muster T, Egorov A, Bergmann M.

J Virol. 2011 Mar;85(5):2469-73. doi: 10.1128/JVI.01650-10. Epub 2010 Dec 22.

13.

Endogenous expression of proteases in colon cancer cells facilitate influenza A viruses mediated oncolysis.

Sturlan S, Stremitzer S, Bauman S, Sachet M, Wolschek M, Ruthsatz T, Egorov A, Bergmann M.

Cancer Biol Ther. 2010 Sep 15;10(6):592-9. Epub 2010 Sep 2.

PMID:
20647775
14.

A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1.

Wacheck V, Egorov A, Groiss F, Pfeiffer A, Fuereder T, Hoeflmayer D, Kundi M, Popow-Kraupp T, Redlberger-Fritz M, Mueller CA, Cinatl J, Michaelis M, Geiler J, Bergmann M, Romanova J, Roethl E, Morokutti A, Wolschek M, Ferko B, Seipelt J, Dick-Gudenus R, Muster T.

J Infect Dis. 2010 Feb 1;201(3):354-62. doi: 10.1086/649428.

PMID:
20039806
15.

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.

Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A.

PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984.

16.

Characterization of NKIP: a novel, Na+/K+-ATPase interacting protein mediates neural differentiation and apoptosis.

Pratscher B, Friedrich C, Goger W, Allen M, Fink D, Thallinger C, Wolschek M, Frei K, Schöfer C, Pehamberger H, Wacheck V, Sorensen PH, Müller M, Jansen B, Lucas T.

Exp Cell Res. 2008 Feb 1;314(3):463-77. Epub 2007 Nov 24.

PMID:
18096156
17.

The human orthologue of a novel apoptosis response gene induced during rat myelomonocytic stem cell apoptosis maps to 20q13.12.

Lucas T, Pratscher B, Fink D, Wolschek M, Samorapoompichit P, Schöfer C, Pehamberger H, Müller M, Sorensen P, Jansen B.

Stem Cells Dev. 2005 Oct;14(5):556-63.

PMID:
16305340
18.

Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide.

Thallinger C, Wolschek MF, Maierhofer H, Skvara H, Pehamberger H, Monia BP, Jansen B, Wacheck V, Selzer E.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4185-91.

19.

Combination allele-specific real-time PCR for differentiation of beta 2-adrenergic receptor coding single-nucleotide polymorphisms.

Lucas T, Losert D, Allen M, Halaschek-Wiener J, Pratscher B, Friedrich C, Wolschek M, Fuchsjäger-Mayrl G, Schmetterer L, Pehamberger H, Müller M, Wacheck V.

Clin Chem. 2004 Apr;50(4):769-72. No abstract available.

20.

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.

Mikula M, Gotzmann J, Fischer AN, Wolschek MF, Thallinger C, Schulte-Hermann R, Beug H, Mikulits W.

Oncogene. 2003 Oct 2;22(43):6725-38.

PMID:
14555986
21.

Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women.

Hirtenlehner K, Pollheimer J, Lichtenberger C, Wolschek MF, Zeisler H, Husslein P, Knöfler M.

J Soc Gynecol Investig. 2003 Oct;10(7):412-7.

PMID:
14519482
22.

Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes.

Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E.

J Control Release. 2003 Aug 28;91(1-2):173-81.

PMID:
12932649
23.

Tissue-dependent factors affect gene delivery to tumors in vivo.

Smrekar B, Wightman L, Wolschek MF, Lichtenberger C, Ruzicka R, Ogris M, Rödl W, Kursa M, Wagner E, Kircheis R.

Gene Ther. 2003 Jul;10(13):1079-88.

PMID:
12808438
24.

Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.

Thallinger C, Wolschek MF, Wacheck V, Maierhofer H, Günsberg P, Polterauer P, Pehamberger H, Monia BP, Selzer E, Wolff K, Jansen B.

J Invest Dermatol. 2003 Jun;120(6):1081-6.

25.

Heterogeneous expression and regulation of CD40 in human hepatocellular carcinoma.

Holub M, Zakeri SM, Lichtenberger C, Pammer J, Paolini P, Leifeld L, Rockenschaub S, Wolschek MF, Steger G, Willheim M, Gangl A, Reinisch W.

Eur J Gastroenterol Hepatol. 2003 Feb;15(2):119-26.

PMID:
12560754
26.

Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.

Wolschek MF, Thallinger C, Kursa M, Rössler V, Allen M, Lichtenberger C, Kircheis R, Lucas T, Willheim M, Reinisch W, Gangl A, Wagner E, Jansen B.

Hepatology. 2002 Nov;36(5):1106-14.

PMID:
12395320
27.

Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity.

Kircheis R, Ostermann E, Wolschek MF, Lichtenberger C, Magin-Lachmann C, Wightman L, Kursa M, Wagner E.

Cancer Gene Ther. 2002 Aug;9(8):673-80.

28.
29.

Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness.

Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H, Mikulits W.

J Cell Sci. 2002 Mar 15;115(Pt 6):1189-202.

30.

Differential expression levels of Par-4 in melanoma.

Lucas T, Pratscher B, Krishnan S, Fink D, Günsberg P, Wolschek M, Wacheck V, Muster T, Romirer I, Wolff K, Pehamberger H, Eichler HG, Rangnekar VM, Jansen B.

Melanoma Res. 2001 Aug;11(4):379-83.

PMID:
11479426
31.

Cyclic AMP- and differentiation-dependent regulation of the proximal alphaHCG gene promoter in term villous trophoblasts.

Knöfler M, Saleh L, Strohmer H, Husslein P, Wolschek MF.

Mol Hum Reprod. 1999 Jun;5(6):573-80.

PMID:
10341006
32.

In situ detection of protein-DNA interactions in filamentous fungi by in vivo footprinting.

Wolschek MF, Narendja F, Karlseder J, Kubicek CP, Scazzocchio C, Strauss J.

Nucleic Acids Res. 1998 Aug 15;26(16):3862-4.

34.

Trehalose-6-phosphate synthase A affects citrate accumulation by Aspergillus niger under conditions of high glycolytic flux.

Arisan-Atac I, Wolschek MF, Kubicek CP.

FEMS Microbiol Lett. 1996 Jun 15;140(1):77-83.

PMID:
8666204
35.

Cre1, the carbon catabolite repressor protein from Trichoderma reesei.

Strauss J, Mach RL, Zeilinger S, Hartler G, Stöffler G, Wolschek M, Kubicek CP.

FEBS Lett. 1995 Nov 27;376(1-2):103-7.

36.

Subcellular compartmentation of penicillin biosynthesis in Penicillium chrysogenum. The amino acid precursors are derived from the vacuole.

Lendenfeld T, Ghali D, Wolschek M, Kubicek-Pranz EM, Kubicek CP.

J Biol Chem. 1993 Jan 5;268(1):665-71.

Supplemental Content

Loading ...
Support Center